It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

Researchers have discovered the first major treatment for asthma attacks in 50 years using a drug called Benralizumab.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...

High levels of eosinophils, also known as eosinophilia, may indicate certain types of cancers and other conditions like parasitic diseases, allergic reactions, autoimmune disorders, and fungal ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...